发明名称 |
Soluble and stable human 5-lipoxygenase |
摘要 |
A soluble and stable form of 5-lipoxygenase (5-LOX) has been made, 5-Lox is the enzyme which initiates leukotriene biosynthesis by catalyzing the two-step transformation of arachidomc acid to leukotriene A4 (LTA4). The soluble and stable 5-LOX is suitable for a number of applications, including, but not limited to, high throughput screening of 5-LOX inhibitors, structural analysis of the enzyme's active site, designing inhibitors based on the three-dimensional structure of the enzyme's active site, and synthesis of LTA4. Using Stable-5-LOX, the crystal structure for 5-LOX has been resolved and the amino acids defining the active site determined. |
申请公布号 |
US8877476(B2) |
申请公布日期 |
2014.11.04 |
申请号 |
US201113700507 |
申请日期 |
2011.05.31 |
申请人 |
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College |
发明人 |
Newcomer Marcia E.;Bartlett Sue G.;Gilbert Nathaniel C. |
分类号 |
C12N9/02;C07H21/04;C12Q1/26 |
主分类号 |
C12N9/02 |
代理机构 |
|
代理人 |
Davis Bonnie J.;Runnels John H. |
主权项 |
1. An isolated 5-Lipoxygenase polypeptide comprising an amino acid sequence, numbered from the N-terminus, as set forth in SEQ ID NO: 1 with one or more of the following modifications selected from the group consisting of:
(a) a replacement of amino acids Tryptophan and Phenylalanine at residues 13-14 with Glutamic acid and Histidine, respectively; (b) a replacement of amino acids Proline, Phenylalanine, Tyrosine, Asparagine and Aspartic Acid at residues 40-44 with Glycine-Serine; (c) a replacement of amino acids Tryptophan and Leucine at residues 75-76 with Glycine and Serine, respectively; (d) a replacement of amino acid Cysteine at residue 240 with Alanine; (e) a replacement of amino acid Cysteine at residue 561 with Alanine; and (f) a replacement of amino acids Lysine, Lysine and Lysine at residues 653-655 with Glutamic acid, Asparagine, and a non-positively charged amino acid, respectively. |
地址 |
Baton Rouge LA US |